Malin Corporation | Kortsiktig Gjeld

Current Liabilities Endring Dato
ALKERMES USD 458.98M 56.7M 2024-03
Avita Medical AUD 11.86M 3.39M 2024-03
Avrobio USD 3.51M 2.84M 2024-03
Dianthus Therapeutics USD 8.96M 672K 2024-03
Eurofins Scientific SE EUR 2.12B 319.9M 2023-12
Ionis Pharmaceuticals USD 327.65M 120.44M 2024-03
IQVIA Holdings USD 6.45B 43M 2024-03
Lonza CHF 2.76B 52M 2023-12
Malin Corporation EUR 1000K 300K 2023-12
Moderna USD 2.38B 635M 2024-03
Organon & Co USD 2.55B 54M 2024-03
Revvity USD 1.37B 76.24M 2024-03
Viatris USD 7.76B 17.5M 2024-03
Xeris Pharmaceuticals USD 73.08M 22.11M 2024-03



Malin Corporation Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.